4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-032382
Chief Medical Officer sold 8,242 shares at $0.77 ($6,346)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2022-05-25 | Sale | −8,242 | $0.77 | $6,346 | 4,087,274 | D |
| Open-market sales · 8,242 sh · avg $0.77 · $6,346 | |||||||
Loading xslF345X03/doc4.xml…